featured
Safety and Effectiveness of Oral Propranolol in Patients With VHL Disease and Retinal Hemangioblastomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMJ Open Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of the Safety and Effectiveness of Oral Propranolol in Patients With Von Hippel-Lindau Disease and Retinal Hemangioblastomas: Phase III Clinical Trial
BMJ Open Ophthalmol 2019 May 28;[EPub Ahead of Print], B González-Rodríguez, K Villar Gómez de Las Heras, DT Aguirre, L Rodríguez-Padial, V Albiñana, L Recio-Poveda, AM Cuesta, LM Botella, RM Jiménez-EscribanoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.